Sandsdal相关文献与解析，生知库 | 链接生命科学的每一步

Holt, Joachim; Holm, Stephanie K; Sandsdal, Rasmus M; Jensen, Simon B K; Juhl, Christian R; Noer, Mikkel H; Afshar-Bahadori, Yasmin; Blond, Martin B; Gerds, Thomas A; Stallknecht, Bente M; Madsbad, Sten; Holst, Jens J; Holst, Birgitte; Hartmann, Bolette; Byberg, Sarah; Torekov, Signe S

肥胖

代谢

发表日期：2026

文献求助收藏

One Year of Exercise After Weight Loss Increases Postprandial GLP-1 Secretion in Contrast to Usual Activity or GLP-1 Receptor Agonist Treatment

减重后坚持运动一年可增加餐后GLP-1分泌，这与日常活动或GLP-1受体激动剂治疗相比，效果不明显。

期刊:

影响因子:

doi:10.1002/oby.70043

Holt, Joachim; Sandsdal, Rasmus Michael; Byberg, Sarah; Janus, Charlotte; Juhl, Christian Rimer; Jørgensen, Julie Rehné; Hartmann, Bolette; Stallknecht, Bente; Holst, Jens Juul; Madsbad, Sten; Jensen, Simon Birk Kjær; Torekov, Signe Sørensen

Weight Loss Induces Changes in Vitamin D Status in Women With Obesity But Not in Men: A Randomized Clinical Trial

一项随机临床试验表明，减肥会改变肥胖女性的维生素D水平，但不会改变男性的维生素D水平。

期刊:Journal of Clinical Endocrinology & Metabolism

影响因子:5.1

doi:10.1210/clinem/dgae775

Holt, Rune; Holt, Joachim; Jorsal, Mads Joon; Sandsdal, Rasmus Michael; Jensen, Simon B K; Byberg, Sarah; Juhl, Christian Rimer; Lundgren, Julie Rehné; Janus, Charlotte; Stallknecht, Bente Merete; Holst, Jens Juul; Juul, Anders; Madsbad, Sten; Jensen, Martin Blomberg; Torekov, Signe Sørensen

Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids

体重维持伴随着循环中 FGF21-脂联素-瘦素和生物活性鞘脂的相互关联的改变。

期刊:Cell Reports Medicine

影响因子:11.7

doi:10.1016/j.xcrm.2024.101629

Matteo Fiorenza ,Antonio Checa ,Rasmus M Sandsdal ,Simon B K Jensen ,Christian R Juhl ,Mikkel H Noer ,Nicolai P Bogh ,Julie R Lundgren ,Charlotte Janus ,Bente M Stallknecht ,Jens Juul Holst ,Sten Madsbad ,Craig E Wheelock ,Signe S Torekov

Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial

通过运动、GLP-1受体激动剂或两者联合治疗维持健康体重减轻，随后停止治疗一年：一项随机安慰剂对照试验的治疗后分析

期刊:EClinicalMedicine

影响因子:10

doi:10.1016/j.eclinm.2024.102475

Jensen, Simon Birk Kjær; Blond, Martin Bæk; Sandsdal, Rasmus Michael; Olsen, Lisa Møller; Juhl, Christian Rimer; Lundgren, Julie Rehné; Janus, Charlotte; Stallknecht, Bente Merete; Holst, Jens Juul; Madsbad, Sten; Torekov, Signe Sørensen

Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial

单独运动、GLP-1受体激动剂治疗或联合治疗对骨骼健康的影响：一项随机临床试验的二次分析

期刊:Jama Network Open

影响因子:9.7

doi:10.1001/jamanetworkopen.2024.16775

Jensen, Simon Birk Kjær; Sørensen, Victor; Sandsdal, Rasmus Michael; Lehmann, Eva Winning; Lundgren, Julie Rehné; Juhl, Christian Rimer; Janus, Charlotte; Ternhamar, Tummas; Stallknecht, Bente Merete; Holst, Jens Juul; Jørgensen, Niklas Rye; Jensen, Jens-Erik Beck; Madsbad, Sten; Torekov, Signe Sørensen

Protocol for a randomised, double-blinded, controlled trial of youth with childhood-onset obesity treated with semaglutide 2.4 mg/week: the RESETTLE trial

一项随机、双盲、对照试验方案，研究每周使用 2.4 mg 司美格鲁肽治疗儿童期起病肥胖症青少年的疗效：RESETTLE 试验

期刊:BMJ Open

影响因子:2.3

doi:10.1136/bmjopen-2023-082446

Byberg, Sarah; Holt, Joachim; Sandsdal, Rasmus Michael; Holm, Louise Aas; Madsen, Lærke Bruun; Christensen, Bodil Just; Jensen, Simon Birk Kjær; Hansen, Torben; Holm, Jens-Christian; Torekov, Signe

Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

运动联合GLP-1受体激动剂治疗可减轻代谢综合征、腹型肥胖和炎症的严重程度：一项随机对照试验

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-023-01765-z

Sandsdal, Rasmus M; Juhl, Christian R; Jensen, Simon B K; Lundgren, Julie R; Janus, Charlotte; Blond, Martin B; Rosenkilde, Mads; Bogh, Adrian F; Gliemann, Lasse; Jensen, Jens-Erik B; Antoniades, Charalambos; Stallknecht, Bente M; Holst, Jens J; Madsbad, Sten; Torekov, Signe S

Insufficient sleep predicts poor weight loss maintenance after 1 year

睡眠不足预示着一年后体重减轻效果难以维持

期刊:Sleep

影响因子:4.9

doi:10.1093/sleep/zsac295

Bogh, Adrian F; Jensen, Simon B K; Juhl, Christian R; Janus, Charlotte; Sandsdal, Rasmus M; Lundgren, Julie R; Noer, Mikkel H; Vu, Nhu Q; Fiorenza, Matteo; Stallknecht, Bente M; Holst, Jens J; Madsbad, Sten; Torekov, Signe S

发表日期：2023

文献求助收藏

Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment

对一项随机对照试验中与饮食和身体活动相关的结果进行探索性分析，该试验旨在评估运动和利拉鲁肽单药或联合治疗维持体重减轻的效果。

期刊:Nature Communications

影响因子:15.7

doi:10.1038/s41467-022-32307-y

Jensen, Simon Birk Kjær; Janus, Charlotte; Lundgren, Julie Rehné; Juhl, Christian Rimer; Sandsdal, Rasmus Michael; Olsen, Lisa Møller; Andresen, Anne; Borg, Signe Amalie; Jacobsen, Ida Christine; Finlayson, Graham; Stallknecht, Bente Merete; Holst, Jens Juul; Madsbad, Sten; Torekov, Signe Sørensen

发表日期：2022

文献求助收藏

Exercise maintains LEAP2 levels after weight loss in females with obesity

运动能够维持肥胖女性减肥后的LEAP2水平

One Year of Exercise After Weight Loss Increases Postprandial GLP-1 Secretion in Contrast to Usual Activity or GLP-1 Receptor Agonist Treatment

减重后坚持运动一年可增加餐后GLP-1分泌，这与日常活动或GLP-1受体激动剂治疗相比，效果不明显。

Weight Loss Induces Changes in Vitamin D Status in Women With Obesity But Not in Men: A Randomized Clinical Trial

一项随机临床试验表明，减肥会改变肥胖女性的维生素D水平，但不会改变男性的维生素D水平。

Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids

体重维持伴随着循环中 FGF21-脂联素-瘦素和生物活性鞘脂的相互关联的改变。

Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial

通过运动、GLP-1受体激动剂或两者联合治疗维持健康体重减轻，随后停止治疗一年：一项随机安慰剂对照试验的治疗后分析

Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial

单独运动、GLP-1受体激动剂治疗或联合治疗对骨骼健康的影响：一项随机临床试验的二次分析

Protocol for a randomised, double-blinded, controlled trial of youth with childhood-onset obesity treated with semaglutide 2.4 mg/week: the RESETTLE trial

一项随机、双盲、对照试验方案，研究每周使用 2.4 mg 司美格鲁肽治疗儿童期起病肥胖症青少年的疗效：RESETTLE 试验

Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

运动联合GLP-1受体激动剂治疗可减轻代谢综合征、腹型肥胖和炎症的严重程度：一项随机对照试验

Insufficient sleep predicts poor weight loss maintenance after 1 year

睡眠不足预示着一年后体重减轻效果难以维持

Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment

对一项随机对照试验中与饮食和身体活动相关的结果进行探索性分析，该试验旨在评估运动和利拉鲁肽单药或联合治疗维持体重减轻的效果。